PG

Poonam Gupta

Active Director Director DIN 08243836
DIN 08243836 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Poonam Gupta

Data last updated:

Poonam Gupta is a Director at Synthiko Formulations & Pharma Private Limited (since 2018). The company operates in Pharma. Synthiko Formulations & Pharma Private Limited reported revenue of ₹2.13 Cr (FY 2020).

DIN 08243836
Primary Designation Director
Industry Pharma
First Appointment 29 Sep 2018
Oldest Company Age 19 yrs
Largest company Synthiko Formulations & Pharma Private Limited · ₹2.13 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Sep 20182007₹2.13 Cr (FY 2020)Active

Board colleagues of Poonam Gupta

Directorship timeline

Open interactive timeline →
Synthiko Formulations & Pharma Private Limited
Premium access

Shareholding and investment profile for Poonam Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Gupta

Poonam Gupta currently holds 1 directorship: Synthiko Formulations & Pharma Private Limited (Director, since 29 Sep 2018, revenue ₹2.13 Cr (FY 2020)).

Poonam Gupta was first appointed on 29 Sep 2018 as Director at Synthiko Formulations & Pharma Private Limited.

The current boards of Poonam Gupta's companies include Mahesh Jaylal Dadhia (Synthiko Formulations & Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available